SE0101257D0 - Treatment of whiplash associated disorder - Google Patents

Treatment of whiplash associated disorder

Info

Publication number
SE0101257D0
SE0101257D0 SE0101257A SE0101257A SE0101257D0 SE 0101257 D0 SE0101257 D0 SE 0101257D0 SE 0101257 A SE0101257 A SE 0101257A SE 0101257 A SE0101257 A SE 0101257A SE 0101257 D0 SE0101257 D0 SE 0101257D0
Authority
SE
Sweden
Prior art keywords
treatment
associated disorder
whiplash associated
whiplash
wad
Prior art date
Application number
SE0101257A
Other languages
Swedish (sv)
Inventor
Kjell Olmarker
Bjoern Rydevik
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Priority to SE0101257A priority Critical patent/SE0101257D0/en
Publication of SE0101257D0 publication Critical patent/SE0101257D0/en
Priority to PCT/SE2002/000672 priority patent/WO2002080892A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The use of a TNF inhibitor for the production of a pharmaceutical composition for treatment of whiplash associated disorder (WAD) is disclosed. Also a method for treatment of whiplash associated disorder (WAD) is disclosed.
SE0101257A 2001-04-06 2001-04-06 Treatment of whiplash associated disorder SE0101257D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0101257A SE0101257D0 (en) 2001-04-06 2001-04-06 Treatment of whiplash associated disorder
PCT/SE2002/000672 WO2002080892A1 (en) 2001-04-06 2002-04-05 Use of tnf inhibitor for treatment of whiplash associated disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101257A SE0101257D0 (en) 2001-04-06 2001-04-06 Treatment of whiplash associated disorder

Publications (1)

Publication Number Publication Date
SE0101257D0 true SE0101257D0 (en) 2001-04-06

Family

ID=20283724

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101257A SE0101257D0 (en) 2001-04-06 2001-04-06 Treatment of whiplash associated disorder

Country Status (2)

Country Link
SE (1) SE0101257D0 (en)
WO (1) WO2002080892A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030064A1 (en) * 2003-01-17 2004-07-18 Italfarmaco Spa USE OF HYDROXAMIC ACID DERIVATIVES FOR PREPARATION

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803710L (en) * 1998-09-25 2000-03-26 A & Science Invest Ab Use of certain substances for the treatment of nerve root damage
US6419944B2 (en) * 1999-02-24 2002-07-16 Edward L. Tobinick Cytokine antagonists for the treatment of localized disorders
US6015557A (en) * 1999-02-24 2000-01-18 Tobinick; Edward L. Tumor necrosis factor antagonists for the treatment of neurological disorders
US6177077B1 (en) * 1999-02-24 2001-01-23 Edward L. Tobinick TNT inhibitors for the treatment of neurological disorders
US6537549B2 (en) * 1999-02-24 2003-03-25 Edward L. Tobinick Cytokine antagonists for the treatment of localized disorders
US20010021380A1 (en) * 1999-04-19 2001-09-13 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders

Also Published As

Publication number Publication date
WO2002080892A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
MY151032A (en) Treatment of tnf? related disorders
MXPA03010134A (en) Substituted cyclohexane-1,4-diamine derivatives.
TW200510375A (en) New compounds
UA84025C2 (en) Normal;heading 1;heading 2;2-(QUINOXALIN-5-YLSULFONYLAMINO)-BENZAMIDE COMPOUNDS AS CCK2 MODULATORS
ATE408601T1 (en) FREDERICAMYCIN DERIVATIVES
WO2003103603A3 (en) Novel formate salt of o-desmethyl-venlafaxine
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
AU3831301A (en) Method for treating ocular pain
DK1311256T3 (en) Use of derivatives of valproic acid amides and 2-valproic acid amides for the treatment or prevention of pain and / or headache disorders
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
WO2003106450A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
ATE202483T1 (en) IMMUNTOLERANT PROTHROMBIN COMPLEX PREPARATION
PT1404304E (en) Tablet comprising cetirizine and pseudoephedrine
WO2003037863A3 (en) Substituted indoles, method for production and use thereof for the inhibition of pain
MXPA04000446A (en) Substituted 4-aminocyclohexanols.
MXPA04004090A (en) Substituted 1h-quinolin-2-one compounds.
CY1110156T1 (en) Substituted Compounds 4,5,6,7-tetrahydro-benzothiiazol-2-ylamine
SE0101257D0 (en) Treatment of whiplash associated disorder
RS50523B (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
SE0004827D0 (en) Therapeutic compounds
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
BR0208593A (en) Method for the treatment of a mammal, compound, and, pharmaceutical composition
ATE308513T1 (en) NAPHTHAMIDE NEUROKININ ANTAGONISTS FOR USE AS MEDICATIONS
AU2003274565A8 (en) Composition for the treatment of nasopharyngeal carcinoma and method of use thereof
ATE444762T1 (en) THERAPEUTIC COMPOSITIONS FOR TOLERANCE INDUCTION